Quick Answer
BIOREGENX, INC. reported Operating Income of -$22.76 million for fiscal year 2024.
BIOREGENX, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$22.76M | -567.8% |
| 2023 | -$3.41M | -4253.1% |
| 2022 | -$78.3K | +52.6% |
| 2021 | -$165.1K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.5K | +97.4% | +92.1% |
| June 30, 2025 | -$107.3K | +89.7% | +44.3% |
| March 31, 2025 | -$192.6K | +93.7% | +41.2% |
| September 30, 2024 | -$327.3K | +86.7% | +68.5% |
| June 30, 2024 | -$1.04M | -90.9% | +66.2% |
| March 31, 2024 | -$3.08M | -3220.0% | -24.7% |
| September 30, 2023 | -$2.47M | -112567.9% | -353.3% |
| June 30, 2023 | -$544.6K | -1537.3% | -487.2% |
- BIOREGENX, INC. showed a decrease of -567.8% in Operating Income compared to the prior fiscal year.
- Over the 2021–2024 period, BIOREGENX, INC.’s operating income has declined by 13686.1% (from -$165.1 thousand to -$22.76 million).
- The most recent figure is from BIOREGENX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: